MA
TMO icon

Montag & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Montag & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.73M Buy
9,619
+566
+6% +$307K 0.22% 95
2025
Q4 		$5.25M Buy
9,053
+322
+4% +$182K 0.24% 84
2025
Q3 		$4.24M Sell
8,731
-4,001
-31% -$1.86M 0.2% 108
2025
Q2 		$5.17M Sell
12,732
-265
-2% -$111K 0.25% 91
2025
Q1 		$6.47M Sell
12,997
-135
-1% -$73.1K 0.32% 74
2024
Q4 		$6.84M Sell
13,132
-200
-2% -$110K 0.32% 70
2024
Q3 		$8.25M Sell
13,332
-276
-2% -$163K 0.39% 65
2024
Q2 		$7.53M Buy
13,608
+55
+0.4% +$31.5K 0.38% 64
2024
Q1 		$7.88M Sell
13,553
-66
-0.5% -$37K 0.39% 63
2023
Q4 		$7.23M Sell
13,619
-109
-0.8% -$52.8K 0.4% 61
2023
Q3 		$6.95M Buy
13,728
+217
+2% +$116K 0.44% 60
2023
Q2 		$7.05M Buy
13,511
+68
+0.5% +$36.7K 0.43% 58
2023
Q1 		$7.75M Sell
13,443
-150
-1% -$84.5K 0.51% 52
2022
Q4 		$7.49M Sell
13,593
-995
-7% -$527K 0.5% 56
2022
Q3 		$7.4M Buy
14,588
+280
+2% +$157K 0.51% 47
2022
Q2 		$7.78M Sell
14,308
-1,934
-12% -$1.06M 0.5% 48
2022
Q1 		$9.59M Sell
16,242
-794
-5% -$456K 0.51% 46
2021
Q4 		$11.4M Sell
17,036
-2,176
-11% -$1.36M 0.56% 44
2021
Q3 		$11M Sell
19,212
-327
-2% -$179K 0.59% 40
2021
Q2 		$9.86M Sell
19,539
-912
-4% -$430K 0.52% 44
2021
Q1 		$9.33M Sell
20,451
-5,790
-22% -$2.76M 0.53% 47
2020
Q4 		$12.2M Sell
26,241
-2,254
-8% -$1.06M 0.75% 34
2020
Q3 		$12.6M Sell
28,495
-1,678
-6% -$693K 1.01% 21
2020
Q2 		$10.9M Sell
30,173
-7,530
-20% -$2.52M 0.96% 23
2020
Q1 		$10.7M Sell
37,703
-1,921
-5% -$606K 1.07% 21
2019
Q4 		$12.9M Sell
39,624
-1,891
-5% -$573K 1.03% 23
2019
Q3 		$12.1M Buy
41,515
+33,569
+422% +$9.61M 1.05% 23
2019
Q2 		$2.33M Buy
7,946
+6,940
+690% +$1.91M 0.21% 109
2019
Q1 		$275K Sell
1,006
-24
-2% -$5.97K 0.03% 266
2018
Q4 		$231K Buy
+1,030
New +$242K 0.02% 263

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Montag & Associates's TMO Position: Q1 2026 in Review

Montag & Associates increased its Thermo Fisher Scientific (TMO) stake by 6.3% in Q1 2026, buying an estimated $307K and bringing the position to 9,619 shares worth $4.73M. The position accounts for 0.22% of the portfolio, ranked #95.

Montag & Associates first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $12.9M in Q4 2019. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Montag & Associates held 9,619 shares of Thermo Fisher Scientific worth $4.73M as of Q1 2026.
  • Montag & Associates bought 566 Thermo Fisher Scientific shares in Q1 2026, an estimated $307K.
  • Thermo Fisher Scientific made up 0.22% of Montag & Associates's portfolio in Q1 2026, its #95 holding.
  • Montag & Associates first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Montag & Associates's Thermo Fisher Scientific position peaked at $12.9M in Q4 2019.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.